Pliant Therapeutics Inc (PLRX)
13.79
-0.19
(-1.36%)
USD |
NASDAQ |
May 06, 16:00
13.79
0.00 (0.00%)
Pre-Market: 20:00
Pliant Therapeutics Free Cash Flow: -117.28M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -117.28M |
| September 30, 2023 | -123.52M |
| June 30, 2023 | -106.40M |
| March 31, 2023 | -105.69M |
| December 31, 2022 | -96.39M |
| September 30, 2022 | -85.44M |
| June 30, 2022 | -89.24M |
| March 31, 2022 | -84.63M |
| December 31, 2021 | -77.40M |
| Date | Value |
|---|---|
| September 30, 2021 | -74.01M |
| June 30, 2021 | -67.14M |
| March 31, 2021 | -39.61M |
| December 31, 2020 | -38.80M |
| September 30, 2020 | 14.83M |
| June 30, 2020 | 16.02M |
| March 31, 2020 | -5.711M |
| December 31, 2019 | -3.714M |
Free Cash Flow Range, Past 5 Years
-123.52M
Minimum
Sep 2023
16.02M
Maximum
Jun 2020
-63.77M
Average
-77.40M
Median
Dec 2021
Free Cash Flow Benchmarks
| Masimo Corp | 6.40M |
| Liquidia Corp | -52.85M |
| Vor Biopharma Inc | -101.36M |
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.10M |
| Cash from Investing (Quarterly) | 31.92M |
| Cash from Financing (Quarterly) | 0.219M |
| Free Cash Flow Per Share (Quarterly) | -0.42 |
| Free Cash Flow Yield | -14.49% |